Company Filing History:
Years Active: 1984-1988
Title: Michael Ruhland: Innovator in Pharmaceutical Chemistry
Introduction
Michael Ruhland is a distinguished inventor based in Hanover, Delaware. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 6 patents. His work focuses on developing innovative compounds that exhibit pharmacological properties, particularly in the area of antidepressant activity.
Latest Patents
Among his latest patents are the Tetraoxo compounds and pharmaceutical compositions. These compounds are characterized by the Formula (I), where R.sup.1 can be an alkyl, alkenyl, phenylalkyl, or cycloalkylalkyl group. Another notable patent involves 3-amino-2,3-dihydro-1-benzoxepine compounds, which correspond to a general Formula I. In this formula, R.sub.1 and R.sub.2 can be hydrogen, halogen, lower alkyl, or lower alkoxy, with additional variations that enhance their pharmacological activity. These compounds are particularly noted for their potential antidepressive effects.
Career Highlights
Michael Ruhland is currently associated with Kali-Chemie Pharma GmbH, where he continues to advance his research and development efforts. His innovative work has positioned him as a key figure in the pharmaceutical industry, contributing to the development of new therapeutic agents.
Collaborations
Michael has collaborated with notable colleagues, including Horst Zeugner and Hans Liepmann. Their combined expertise has fostered a productive environment for innovation and discovery in pharmaceutical chemistry.
Conclusion
Michael Ruhland's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in therapeutic compounds that can significantly impact patient care.